Fanconi's syndrome in HIV+ adults: Report of three cases and literature review

Journal of Bone and Mineral Research

Volumn 19, Issue 5, 2004, Pages 714-721

  Earle, Karen E ^a   Seneviratne, Tara ^a,b   Shaker, Joseph ^c   Shoback, Dolores ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PALO ALTO MEDICAL FOUNDATION   (United States)

^c ST LUKE S MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Bone mineralization; Osteomalacia; Vitamin D

Indexed keywords

ACYCLIC NUCLEOSIDE; ADEFOVIR; ANTIRETROVIRUS AGENT; CIDOFOVIR; PHOSPHATE; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR; ADENINE; CALCITRIOL; CALCIUM; DRUG DERIVATIVE; ORGANOPHOSPHORUS COMPOUND;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FANCONI RENOTUBULAR SYNDROME; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY TUBULE DISORDER; LITERATURE; PATIENT MONITORING; BLOOD; BONE DENSITY; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; MALE; METABOLISM; MIDDLE AGED; REVIEW; URINE; VIROLOGY;

ADENINE; ADULT; ANTI-RETROVIRAL AGENTS; BONE DENSITY; CALCITRIOL; CALCIUM; FANCONI SYNDROME; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHATES; PHOSPHONIC ACIDS;

EID: 3242807577     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2004.19.5.714     Document Type: Article

References (34)

1. Santer R, Schneppenheim R, Suter D, Schaub J, Steinmann B 1998 Fanconi-Bickel syndrome - the original patient and his natural history, historical steps leading to the primary defect, and a review of the literature. Eur J Pediatr 157:783-797.
2. Morris RC Jr 1968 An experimental renal acidification defect in patients with hereditary fructose intolerance. II. Its distinction from classic renal tubular acidosis; its resemblance to the renal acidification defect associated with the Fanconi syndrome of children with cystinosis. J Clin Invest 47:1648-1663.
3. Nissenkorn A, Korman SU, Vardi O, Levine A, Katzir Z, Ballin A, Lerman-Sagie T 2001 Carnitine-deficient myopathy as a presentation of tyrosinemia type I. J Child Neurol 16:642-644.
4. Muller D, Santer R, Krawinkel M, Christiansen B, Schaub J 1997 Fanconi-Bickel syndrome presenting in neonatal screening for galactosaemia. J Inherit Metab Dis 20:607-608.
5. Monro P 1970 Effect of treatment on renal function in severe osteomalacia due to Wilson's disease. J Clin Pathol 23:487-491.
6. Papadopoulos NM, Costello R, Charnas L, Adamson MD, Gahl WA 1989 Electrophoretic examination of proteinuria in Lowe's syndrome and other causes of renal tubular Fanconi syndrome. Clin Chem 35:2231-2233.
7. Elpeleg ON 1999 The molecular background of glycogen metabolism disorders. J Pediatr Endocrinol Metab 12:363-379.
8. Adams RG, Harrison JF, Scott P 1969 The development of cadmium-induced proteinuria, impaired renal function, and osteomalacia in alkaline battery workers. Q J Med 38:425-443.
9. Rao DS, Parfitt AM, Villanueva AR, Dorman PJ, Kleerekoper M 1987 Hypophosphatemic osteomalacia and adult Fanconi syndrome due to light-chain nephropathy. Another form of oncogenous osteomalacia. Am J Med 82:333-338.
10. Melnick JZ, Baum M, Thompson JR 1994 Aminoglycoside-induced Fanconi's syndrome. Am J Kidney Dis 23:118-122.
11. Yoshikawa H, Watanabe T, Abe T 2002 Fanconi syndrome caused by sodium valproate: Report of three severely disabled children. Eur J Paediatr Neurol 6:165-167.
12. Otten J, Vis HL 1968 Acute reversible renal tubular dysfunction following intoxication with methyl-3-chromone. J Pediatr 73:422-425.
13. Vaziri ND, Ness RL, Fairshter RD, Smith WR, Rosen SM 1979 Nephrotoxicity of paraquat in man. Arch Intern Med 139:172-174.
14. Lo JC, Chertow GM, Rennke H, Seifter JL 1996 Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion. Am J Kidney Dis 28:614-617.
15. Varavithya W, Chulajata R, Ayudthya PS, Preeyasombat C 1971 Fanconi syndrome caused by degraded tetracycline. J Med Assoc Thai 54:62-67.
16. Montoliu J, Carrera M, Darnell A, Revert L 1981 Lactic acidosis and Fanconi's syndrome due to degraded tetracycline. BMJ 283: 1576-1577.
17. Vittecoq D, Dumitrescu L, Beaufils H, Deray G 1997 Fanconi syndrome associated with cidofovir therapy. Antimicrob Agents Chemother 41:1846.
18. Klotman PE 1999 HIV-associated nephropathy. Kidney Int 56:1161-1176.
19. Morris AA, Baudouin SV, Snow MH 2001 Renal tubular acidosis and hypophosphataemia after treatment with nucleoside reverse transcriptase inhibitors. AIDS 15:140-141.
20. Verhelst D, Monge M, Meynard JL, Fouqueray B, Mougenot B, Girard PM, Ronco P, Rossert J 2002 Fanconi syndrome and renal failure induced by tenofovir: A first case report. Am J Kidney Dis 40:1331-1333.
21. Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G 2003 Drug-induced Fanconi's syndrome. Am J Kidney Dis 41:292-309.
22. Callens S, De Roo A, Colebunders R 2003 Fanconi-like syndrome and rhabdomyolysis in a person with HIV infection on highly active antiretroviral treatment including tenofovir. J Infect 47:262-263.
23. Creput C, Gonzalez-Canali G, Hill G, Piketty C, Kazatchkine M, Nochy D 2003 Renal lesions in HIV-1-positive patient treated with tenofovir. AIDS 17:935-937.
24. Karras A, Lafaurie M, Furco A, Bourgarit A, Droz D, Sereni D, Legendre C, Martinez F, Molina JM 2003 Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: Three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. Clin Infect Dis 36:1070-1073.
25. Bergoron MGA, Vinay P 1995 The renal Fanconi syndrome. In: Scriver CR, et al. (eds.) The Metabolic and Molecular Bases of Inherited Diseases. McGraw-Hill, New York, NY, USA, pp. 3691-3704.
26. Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA 1995 Osteomalacia associated with adult Fanconi's syndrome: Clinical and diagnostic features. Clin Endocrinol (Oxf) 43:479-490.
27. Walker UA 2003 Update on mitochondrial toxicity: Where are we now? J HIV Ther 8:32-35.
28. Miller RF, Shahmonesh M, Hanna MG, Unwin RJ, Schapira AH, Weller IV 2003 Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors. Antivir Ther 8:253-257.
29. Tengan CH, Kiyomoto BH, Rocha MS, Tavares VL, Gabbai AA, Moraes CT 1998 Mitochondrial encephalomyopathy and hypoparathyroidism associated with a duplication and a deletion of mitochondrial deoxyribonucleic acid. J Clin Endocrinol Metab 83:125-129.
30. Cihlar T, Ho ES, Lin DC, Mulato AS 2001 Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleolide analogs. Nucleosides Nucleotides Nucleic Acids 20:641-648.
31. Ho ES, Lin DC, Mendel DB, Cihlar T 2000 Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J Am Soc Nephrol 11:383-393.
32. Tanji N, Tanji K, Kambham N, Markowitz GS, Bell A, D'Agati VD 2001 Adefovir nephrotoxicity: Possible role of mitochondrial DNA depletion. Hum Pathol 32:734-740.
33. Moyle G 2000 Toxicity of antiretroviral nucleoside and nucleotide analogues: Is mitochondrial toxicity the only mechanism? Drug Saf 23:467-481.
34. Birkus G, Hitchcock MJ, Cihlar T 2002 Assessment of mitochondrial toxicity in human cells treated with tenofovir: Comparison with other nucleoside reverse transcriptase inhibitors. Antimicrob Agents Chemother 46:716-723.